Deepak Nitrite's subsidiary approves ₹2,500 Crore Bisphenol A project
Deepak Nitrite's subsidiary, Deepak Chem Tech Limited, has approved a project to manufacture Bisphenol A (BPA) with a capacity of 240 KTA. The investment is around ₹2,500 Crores. This move creates an integrated platform from Cumene to Polycarbonate resin.
The project involves a substantial investment of ₹2,500 Crores and adds a key product (BPA) to the company's integrated value chain, which is expected to have a significant impact on its business and market position.
The company is undertaking a significant capital expenditure to expand its product portfolio and create an integrated manufacturing platform, which is positive for future growth.
Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite Limited, has received board approval for a new project to manufacture Bisphenol A (BPA) with a capacity of up to 240 KTA. This project also includes related greenfield infrastructure and capital expenditure for the manufacturing complex.
The investment for this project is estimated at approximately ₹2,500 Crores, which will be finalized upon completion of detailed engineering. The funding will be sourced through a combination of debt and equity.
This BPA project complements DCTL's previously approved ventures, including India's first Polycarbonate resin manufacturing plant leveraging Trinseo technology and a Phenol & Acetone manufacturing plant. With the addition of BPA, Deepak Nitrite aims to establish a highly integrated manufacturing platform covering the value chain from Cumene to Phenol & Acetone, BPA, and Polycarbonate resin, including downstream compounding. The BPA facility will cater to captive requirements for Polycarbonate resin production and address the growing Indian market demand for BPA, which is used in manufacturing Epoxy resins.
What to do with a filing like this
Deepak Nitrite Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Deepak Nitrite Limited. Read the original for the full detail.